Edition:
India

Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

581.50INR
10:04am IST
Change (% chg)

Rs-0.55 (-0.09%)
Prev Close
Rs582.05
Open
Rs582.70
Day's High
Rs582.85
Day's Low
Rs576.30
Volume
446,967
Avg. Vol
4,330,192
52-wk High
Rs854.95
52-wk Low
Rs492.65

SUN.NS

Chart for SUN.NS

About

Sun Pharmaceutical Industries Limited is a pharmaceuticals company. The Company's business segments include US Business, Indian Branded Generics Business, Emerging Markets, Global Consumer Healthcare Business and Active Pharmaceutical Ingredients (API). Its Rest of World segment includes Western Europe, Canada, Australia, New... (more)

Overall

Beta: 0.08
Market Cap(Mil.): Rs1,413,551.00
Shares Outstanding(Mil.): 2,399.31
Dividend: 3.50
Yield (%): 0.17

Financials

  SUN.NS Industry Sector
P/E (TTM): 20.37 13.49 17.10
EPS (TTM): 28.92 -- --
ROI: 20.08 -7.23 -5.56
ROE: 20.01 -6.74 -4.84

BRIEF-Sun Pharma Advanced Research Co seeks members' nod to approve transactions with Sun Pharmaceutical Industries Inc

* Seeks members' nod to approve transactions with Sun Pharmaceutical Industries Inc, USA

10 Jul 2017

BRIEF-Sun Pharmaceutical Industries announces manufacturing tie-up with Samsung Biologics

* Strategic manufacturing tie-up with Samsung Biologics for Tildrakizumab

04 Jul 2017

BRIEF-Sun Pharma, NIV in pact to test biologic, chemical entities against zika,chikungunya, dengue

* Sun Pharma & NIV sign agreement to fight zika, chikungunya and dengue

27 Jun 2017

BRIEF-Sun Pharma Industries gets members' nod for scheme of arrangement with Sun Pharma Medisales, Ranbaxy Drugs, others

* Gets members' nod for scheme of arrangement among Sun Pharma Medisales, Ranbaxy Drugs, Gufic Pharma, Vidyut Investments, co Source text - (http://bit.ly/2tQBUuR) Further company coverage:

22 Jun 2017

BRIEF-Sun Pharma Industries' members approve co's scheme of arrangement with Sun Pharma Medisales, Ranbaxy Drugs, others

* Scheme of arrangement with Sun Pharma Medisales,Ranbaxy Drugs, Gufic Pharma,Vidyut Investments approved by members,unsecured creditors Source text: http://bit.ly/2sOhXZj Further company coverage:

20 Jun 2017

BRIEF-Sun Pharmaceutical Industries says US FDA approval for generic zetia tablets

* Says Sun Pharma announces US FDA approval for generic zetia tablets

13 Jun 2017

BUZZ-India's Sun Pharma plunges to 3-1/2-yr low; Q4 profit falls 14 pct

** Shares of Sun Pharmaceutical Industries Ltd plunge as much as 12.8 pct to 494.85 rupees, to their lowest since Aug 29, 2013

29 May 2017

Sun Pharma says 2018 sales may fall as U.S. market gets tougher

MUMBAI India's largest drug group Sun Pharmaceutical Industries Ltd said on Friday its U.S. sales might fall this year because of pressure on drug prices, signalling tough market conditions in the United States for generic drugmakers.

27 May 2017

Sun Pharma says 2018 sales may fall as U.S. market gets tougher

MUMBAI India's largest drug group Sun Pharmaceutical Industries Ltd said on Friday its U.S. sales might fall this year because of pressure on drug prices, signalling tough market conditions in the United States for generic drugmakers.

26 May 2017

UPDATE 1-India's Sun Pharma says 2018 sales may fall as U.S. market gets tougher

* Q4 U.S. sales slide 34 pct (Adds Managing Director comments from conference call)

26 May 2017

Earnings vs. Estimates